AB 173Session 2025
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Progress
- Introduced
- In committee
- Passed one chamber Not yet
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
What this bill would cost
Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.
Legislative history
-
House
Failed to pass pursuant to Senate Joint Resolution 1
-
House
Representative Bare added as a coauthor
-
House
Representative Franklin added as a coauthor
-
House
Representatives Stubbs and Hysell added as coauthors
-
House
Public hearing held
-
House
Assembly Amendment 1 offered by Representative Novak
-
House
Representative Andraca added as a coauthor
-
House
Senator Carpenter added as a cosponsor
-
House
Representative Cruz added as a coauthor
-
House
Representative Donovan added as a coauthor
-
House
Representative Sinicki added as a coauthor
-
House
Representative J. Jacobson added as a coauthor
-
House
Representative Palmeri added as a coauthor
-
House
Fiscal estimate received
-
House
Representative Emerson added as a coauthor
-
House
Representative Udell added as a coauthor
-
House
Senator Smith added as a cosponsor
-
House
Representative Ortiz-Velez added as a coauthor
-
House
Fiscal estimate received
-
House
Representative Rivera-Wagner added as a coauthor
-
House
Read first time and referred to Committee on Health, Aging and Long-Term Care
-
House
Introduced by Representatives Novak, Tranel, Allen, Armstrong, Brooks, Callahan, Fitzgerald, B. Jacobson, Joers, Kirsch, Kitchens, Knodl, Kreibich, McCarville, Miresse, Mursau, O'Connor, Sortwell, Tittl, Wichgers and Tucker; cosponsored by Senators Felzkowski, Marklein, Cabral-Guevara, Dassler-Alfheim, Drake, Habush Sinykin, L. Johnson, Keyeski, Larson, Nass, Pfaff, Quinn, Ratcliff, Roys, Spreitzer, Wanggaard, Wimberger and James